Model Answer
0 min readIntroduction
Extra-pulmonary tuberculosis (EPTB) refers to tuberculosis affecting organs other than the lungs. It constitutes a significant proportion of TB cases globally, with increasing prevalence due to HIV co-infection and immunocompromised states. Accurate and timely diagnosis of EPTB is challenging due to its varied clinical presentations and often paucibacillary nature. Diagnosis relies on a combination of clinical suspicion, imaging, microbiological tests, histopathology, and immunological assays. Early diagnosis is crucial for initiating appropriate treatment and preventing morbidity and mortality. The World Health Organization estimates that approximately 15% of new TB cases are EPTB, though this varies geographically.
Diagnostic Modalities for Extra-Pulmonary Tuberculosis
1. Imaging Techniques
Imaging plays a crucial role in identifying EPTB, especially in sites difficult to access for biopsy.
- Chest X-ray: While primarily used for pulmonary TB, it can reveal signs of mediastinal lymphadenopathy or pleural effusion suggestive of EPTB.
- Computed Tomography (CT) Scan: Provides detailed anatomical information and is useful for diagnosing lymph node TB, abdominal TB, and skeletal TB. Contrast-enhanced CT can help differentiate between active and healed lesions.
- Magnetic Resonance Imaging (MRI): Superior for soft tissue imaging, particularly useful in diagnosing spinal TB (Pott’s disease), brain TB (tuberculous meningitis), and musculoskeletal TB.
- Ultrasound: Useful for guiding fine needle aspiration cytology (FNAC) of lymph nodes and for detecting abdominal TB (ascites, hepatosplenomegaly).
- Positron Emission Tomography (PET) Scan: Can help differentiate between active and inactive TB lesions, particularly useful in evaluating treatment response.
2. Microbiological Techniques
These techniques aim to identify Mycobacterium tuberculosis directly from clinical specimens.
- Smear Microscopy: Rapid and inexpensive, but has low sensitivity, especially in EPTB due to paucibacillary nature. Uses Ziehl-Neelsen or fluorescent staining.
- Culture: Gold standard for TB diagnosis, but slow (6-8 weeks). Solid media (Lowenstein-Jensen) and liquid media (MGIT) are used. Drug susceptibility testing (DST) can be performed on isolates.
- Nucleic Acid Amplification Tests (NAATs): Rapid molecular tests like Xpert MTB/RIF detect M. tuberculosis and rifampicin resistance within hours. Highly sensitive and specific, particularly useful for cerebrospinal fluid (CSF) in tuberculous meningitis.
3. Histopathological Examination
Involves microscopic examination of tissue biopsies to identify granulomas and acid-fast bacilli (AFB).
- Biopsy: Essential for confirming EPTB in most sites (lymph nodes, pleura, peritoneum, bones).
- Acid-Fast Bacilli (AFB) Staining: Identifies M. tuberculosis in tissue sections.
- Granuloma Formation: Characteristic feature of TB, but not specific.
- PCR on Biopsy Material: Can confirm the presence of M. tuberculosis DNA in tissue samples.
4. Immunological Tests
These tests assess the host's immune response to M. tuberculosis.
- Tuberculin Skin Test (TST): Measures delayed-type hypersensitivity to TB antigens. Limited utility in immunocompromised individuals and those previously vaccinated with BCG.
- Interferon-Gamma Release Assays (IGRAs): More specific than TST, as they measure interferon-gamma production in response to TB antigens. Less affected by BCG vaccination. Examples include QuantiFERON-TB Gold and T-SPOT.TB.
- Adenosine Deaminase (ADA) levels: Elevated ADA levels in pleural fluid, ascitic fluid, and CSF are suggestive of TB, but not specific.
5. Site-Specific Diagnostic Approaches
Diagnosis often requires a tailored approach based on the affected organ.
- Tuberculous Meningitis: CSF analysis (cell count, protein, glucose, ADA), NAAT (Xpert MTB/RIF), CT/MRI scan.
- Lymph Node TB: FNAC with AFB staining and PCR, lymph node biopsy with histopathology.
- Skeletal TB: Imaging (X-ray, MRI), biopsy of affected bone.
- Abdominal TB: Imaging (CT scan, ultrasound), ascitic fluid analysis (ADA, AFB staining, PCR), peritoneal biopsy.
Conclusion
Diagnosing EPTB requires a multifaceted approach, integrating clinical assessment with a range of diagnostic modalities. While microbiological confirmation remains the gold standard, imaging and immunological tests play crucial roles, particularly in paucibacillary forms. The choice of diagnostic tests should be guided by the clinical presentation and the site of involvement. Advancements in molecular diagnostics, like Xpert MTB/RIF, have significantly improved the speed and accuracy of EPTB diagnosis, leading to earlier treatment initiation and improved patient outcomes. Continued research is needed to develop more sensitive and specific diagnostic tools for EPTB.
Answer Length
This is a comprehensive model answer for learning purposes and may exceed the word limit. In the exam, always adhere to the prescribed word count.